What Is Inositol?
Inositol is a sugar alcohol naturally present in the body and in many foods, including fruits, beans, grains, and nuts. Although sometimes referred to as vitamin B8, inositol is not technically a vitamin since the body can synthesize it. The two most studied forms are myo-inositol (MI) and D-chiro-inositol (DCI), both of which play critical roles in insulin signaling, cell membrane formation, and neurotransmitter activity. Over the past two decades, inositol has emerged as one of the most well-researched natural compounds for hormonal, metabolic, and mental health conditions.
PCOS Symptom Improvement
Polycystic ovary syndrome (PCOS) is the condition for which inositol has the strongest and most extensive clinical evidence. PCOS affects an estimated 8-13% of women of reproductive age worldwide and is characterized by hormonal imbalance, insulin resistance, irregular periods, and ovarian cysts.
Multiple randomized controlled trials have demonstrated that myo-inositol supplementation significantly improves core PCOS symptoms. A landmark meta-analysis published in Endocrine Connections found that myo-inositol reduced fasting insulin, total testosterone, and androstenedione levels while improving menstrual regularity in women with PCOS (Unfer et al., 2017). These hormonal improvements translate into meaningful clinical outcomes: less acne, reduced hirsutism, and more predictable cycles.
The International Consensus Conference on Myo-Inositol and D-Chiro-Inositol in Obstetrics and Gynecology has formally recognized inositol as a first-line approach for PCOS management, particularly for women who prefer a non-pharmaceutical option or who experience side effects from metformin (Facchinetti et al., 2015).
A 2025 randomized clinical trial published in JAMA further confirmed that myo-inositol supplementation prevents pregnancy complications in women with PCOS, underscoring its clinical relevance beyond menstrual regulation alone (van der Wel et al., 2025).
Insulin Sensitization
Inositol functions as a second messenger in the insulin signaling cascade. In cells, myo-inositol is converted into inositol phosphoglycans (IPGs) that mediate insulin’s metabolic effects, including glucose uptake and glycogen synthesis. When this pathway is disrupted, as it commonly is in PCOS and metabolic syndrome, supplemental inositol can help restore normal insulin sensitivity.
A study published in Gynecological Endocrinology showed that myo-inositol supplementation significantly reduced HOMA-IR (a standard measure of insulin resistance) in women with PCOS, with effects comparable to metformin but with fewer gastrointestinal side effects (Zacchè et al., 2009). This insulin-sensitizing effect is considered the upstream mechanism behind many of inositol’s downstream benefits for PCOS, fertility, and metabolic health.
Ovulation Restoration
One of the most impactful benefits of inositol for women with PCOS is its ability to restore ovulatory cycles. Anovulation (failure to ovulate) is a primary cause of infertility in PCOS, driven largely by hyperinsulinemia and excess androgens.
Research published in Gynecological Endocrinology demonstrated that myo-inositol supplementation restored spontaneous ovulation in a significant proportion of women with PCOS-related anovulation. In one trial, 65% of women treated with myo-inositol resumed regular ovulatory cycles within six months, compared to 50% in the metformin group (Raffone et al., 2010). This ovulation-restoring effect has made inositol a widely adopted tool in reproductive endocrinology.
Panic Disorder and Anxiety
Inositol plays a fundamental role in the phosphatidylinositol (PI) signaling system, which is involved in serotonin and other neurotransmitter receptor function. This biochemical role underpins its effects on mental health.
A double-blind, controlled crossover trial published in the Journal of Clinical Psychopharmacology found that 18 g/day of inositol significantly reduced the frequency and severity of panic attacks, with efficacy comparable to fluvoxamine (an SSRI) but with far fewer side effects (Palatnik et al., 2001). An earlier study also demonstrated that inositol at 12 g/day was effective for panic disorder compared to placebo (Benjamin et al., 1995).
These results are particularly noteworthy because inositol achieved comparable outcomes to SSRIs without the sexual side effects, weight gain, or withdrawal symptoms commonly associated with those medications.
OCD Symptom Reduction
Obsessive-compulsive disorder (OCD) is another serotonin-mediated condition for which inositol has shown benefit. A double-blind, placebo-controlled trial published in the American Journal of Psychiatry found that 18 g/day of inositol for six weeks significantly reduced OCD symptoms as measured by the Yale-Brown Obsessive Compulsive Scale (Fux et al., 1996). While the effect size was moderate, inositol’s favorable side effect profile makes it a compelling adjunctive or alternative option for individuals who do not tolerate or fully respond to SSRIs.
Fertility and IVF Egg Quality
Beyond restoring natural ovulation, inositol has demonstrated specific benefits in the context of assisted reproduction. Myo-inositol is found at high concentrations in human follicular fluid, and its levels correlate positively with oocyte (egg) quality.
Research shows that women undergoing IVF who supplement with myo-inositol produce higher-quality oocytes, require lower doses of gonadotropins (fertility drugs), and have higher fertilization rates. The combination of myo-inositol and D-chiro-inositol in a 40:1 ratio has also shown improvements in embryo quality and clinical pregnancy rates in IVF patients (Colazingari et al., 2013). A 2024 systematic review and meta-analysis confirmed that myo-inositol supplementation improves ART (assisted reproductive technology) outcomes in women with PCOS, including fertilization rates and embryo quality (Sene et al., 2025).
A 2024 network meta-analysis comparing metformin, anti-obesity agents, and myoinositol for IVF outcomes found myoinositol was among the most favorably tolerated options with comparable efficacy improvements to pharmaceutical approaches (Lin et al., 2024).
Gestational Diabetes Prevention
Gestational diabetes mellitus (GDM) is a growing concern worldwide, and inositol has been studied as a preventive strategy in at-risk pregnant women. A randomized controlled trial published in Diabetes Care found that 4 g/day of myo-inositol, started in early pregnancy, reduced the incidence of GDM by approximately 65% in women with a family history of type 2 diabetes (D’Anna et al., 2013). A subsequent trial confirmed a significant reduction in GDM incidence among obese pregnant women supplementing with myo-inositol (D’Anna et al., 2015). A 2024 systematic review further validated this effect across multiple populations (Asimakopoulos et al., 2024).
These findings are notable because few interventions have demonstrated the ability to prevent GDM, and inositol’s safety during pregnancy is well established.
Metabolic Syndrome Markers
Metabolic syndrome, a cluster of risk factors including abdominal obesity, elevated triglycerides, high blood pressure, and dysregulated blood sugar, is another area where inositol shows therapeutic promise. Studies in postmenopausal women with metabolic syndrome have shown that myo-inositol supplementation (4 g/day) reduces blood pressure, serum triglycerides, and total cholesterol while improving HDL cholesterol and insulin sensitivity (Santamaria et al., 2012).
These metabolic effects suggest that inositol may have broader cardiovascular protective properties beyond its established role in PCOS.
Thyroid Health Support
Emerging evidence supports a role for myo-inositol in thyroid function, particularly in autoimmune thyroiditis (Hashimoto’s). A 2022 randomized trial in Frontiers in Endocrinology found that the combination of myo-inositol and selenium significantly improved TSH levels, thyroid antibody markers (TPO-Ab and Tg-Ab), and symptoms in women with autoimmune thyroiditis compared to selenium alone (Payer et al., 2022). The mechanism involves myo-inositol’s role in TSH signaling through the phosphoinositide pathway in thyroid follicular cells.
Skin Benefits: Acne via Hormonal Mechanisms
Hormonal acne, particularly the type associated with PCOS, is driven by excess androgens and insulin resistance. Because inositol addresses both of these root causes, it can improve acne as a downstream effect. A study in young women with PCOS found that myo-inositol treatment produced clinically meaningful reductions in acne severity alongside improvements in menstrual regularity and testosterone levels (Zacchè et al., 2009). The hormonal normalization that inositol promotes provides a plausible and evidence-supported mechanism for skin improvement.
Summary
Inositol is one of the best-studied natural compounds for hormonal and metabolic health. Its strongest evidence base is in PCOS management and panic disorder treatment, but meaningful clinical data also supports its use for fertility enhancement, gestational diabetes prevention, metabolic syndrome, thyroid support, and OCD symptom reduction. With a favorable safety profile and mechanisms of action that address root causes rather than just symptoms, inositol has earned a prominent place in integrative and reproductive medicine.